$IDXG Balance Sheet | Understand Stock

$IDXG

$6.91 +$0.40 (6.18%) Close

$IDXG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Nov 7, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable
Other current assets
Current assets of discontinued operations
Total current assets

Property and equipment, net
Goodwill
Other intangible assets, net
Operating lease right of use assets
Deferred tax asset
Other long-term assets
Long-term assets of discontinued operations
Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued salary and bonus
Notes payable - related parties
Other accrued expenses
Convertible debt
Note payable at fair value, current
Line of credit - current
Current liabilities of discontinued operations
Total current liabilities

Contingent consideration
Operating lease liabilities, net of current portion
Long term line of credit
Note payable at fair value
Other long-term liabilities
Long-term liabilities of discontinued operations
Total liabilities
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 0 and 47,000 shares Series B issued and outstanding, respectively
Stockholders’ equity:
Common stock, $.01 par value; 100,000,000 shares authorized; 27,844,994 and 4,569,333 shares issued, respectively; 27,700,904 and 4,428,539 shares outstanding, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost (144,090 and 140,794 shares, respectively)
Total stockholders’ equity
Total liabilities and stockholders’ deficit
Total liabilities and stockholders’ equity

Comments